Literature DB >> 33951246

Comprehensive Analysis of Binding Sites in Tubulin.

Tobias Mühlethaler1, Dario Gioia2, Andrea E Prota1, May E Sharpe3, Andrea Cavalli2,4, Michel O Steinmetz1,5.   

Abstract

Tubulin plays essential roles in vital cellular activities and is the target of a wide range of proteins and ligands. Here, using a combined computational and crystallographic fragment screening approach, we addressed the question of how many binding sites exist in tubulin. We identified 27 distinct sites, of which 11 have not been described previously, and analyzed their relationship to known tubulin-protein and tubulin-ligand interactions. We further observed an intricate pocket communication network and identified 56 chemically diverse fragments that bound to 10 distinct tubulin sites. Our results offer a unique structural basis for the development of novel small molecules for use as tubulin modulators in basic research applications or as drugs. Furthermore, our method lays down a framework that may help to discover new pockets in other pharmaceutically important targets and characterize them in terms of chemical tractability and allosteric modulation.
© 2021 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH.

Entities:  

Keywords:  crystallographic fragment screening; microtubules; molecular dynamics simulation; protein-ligand interactions; tubulin

Year:  2021        PMID: 33951246     DOI: 10.1002/anie.202100273

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  9 in total

Review 1.  Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspective.

Authors:  Jiaxing Wang; Duane D Miller; Wei Li
Journal:  Drug Discov Today       Date:  2021-12-08       Impact factor: 7.851

2.  Structural convergence for tubulin binding of CPAP and vinca domain microtubule inhibitors.

Authors:  Valérie Campanacci; Agathe Urvoas; Liza Ammar Khodja; Magali Aumont-Nicaise; Magali Noiray; Sylvie Lachkar; Patrick A Curmi; Philippe Minard; Benoît Gigant
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-04       Impact factor: 12.779

3.  Unveiling the Possible Oryzalin-Binding Site in the α-Tubulin of Toxoplasma gondii.

Authors:  Rodrigo Aguayo-Ortiz; Laura Dominguez
Journal:  ACS Omega       Date:  2022-05-24

4.  Characterization of Caerulomycin A as a dual-targeting anticancer agent.

Authors:  Lingying Tong; Weichao Sun; Shiyong Wu; Yong Han
Journal:  Eur J Pharmacol       Date:  2022-03-23       Impact factor: 5.195

5.  Synthesis and Biological Activity Screening of Newly Synthesized Trimethoxyphenyl-Based Analogues as Potential Anticancer Agents.

Authors:  Tarfah Al-Warhi; Matokah Abualnaja; Ola A Abu Ali; Fayez Althobaiti; Fahad Alharthi; Fahmy G Elsaid; Ali A Shati; Eman Fayad; Doaa Elghareeb; Ali H Abu Almaaty; Islam Zaki
Journal:  Molecules       Date:  2022-07-20       Impact factor: 4.927

6.  Rational Design of a Novel Tubulin Inhibitor with a Unique Mechanism of Action.

Authors:  Tobias Mühlethaler; Lampros Milanos; Jose Antonio Ortega; Thorsten B Blum; Dario Gioia; Bibhas Roy; Andrea E Prota; Andrea Cavalli; Michel O Steinmetz
Journal:  Angew Chem Int Ed Engl       Date:  2022-04-25       Impact factor: 16.823

Review 7.  The Search for Antibacterial Inhibitors Targeting Cell Division Protein FtsZ at Its Nucleotide and Allosteric Binding Sites.

Authors:  José M Andreu; Sonia Huecas; Lidia Araújo-Bazán; Henar Vázquez-Villa; Mar Martín-Fontecha
Journal:  Biomedicines       Date:  2022-07-28

Review 8.  The microtubule cytoskeleton: An old validated target for novel therapeutic drugs.

Authors:  Laurence Lafanechère
Journal:  Front Pharmacol       Date:  2022-09-15       Impact factor: 5.988

9.  Molecular Evolution of Tubulins in Diatoms.

Authors:  Kirill V Khabudaev; Darya P Petrova; Yekaterina D Bedoshvili; Yelena V Likhoshway; Mikhail A Grachev
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.